Home » Cephalon Announces Agreement to Acquire AMRIX, a Once-Daily Extended-Release Muscle Relaxant
Cephalon Announces Agreement to Acquire AMRIX, a Once-Daily Extended-Release Muscle Relaxant
Cephalon announced it has signed an agreement to acquire the North American rights to Amrix (cyclobenzaprine hydrochloride extended-release capsules) from ECR Pharmaceuticals, a privately held company.
Cephalon
Upcoming Events
-
07May
-
14May
-
30May